Is the price fair?
What ALVO's price assumes
Alvotech trades at 52.1× earnings against 24.3× for the median Drug Manufacturers - Specialty & Generic name, more expensive than its own group.
52.1
Trailing P/E · Drug Manufacturers - Specialty & Generic median 24.3 · 2.15× the median: the market pays up for this one
Details›
- Healthcare median P/E362 names
- 29.9
- Drug Manufacturers - Specialty & Generic median P/E32 names
- 24.3
- Market capitalisation
- $1.18B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Drug Manufacturers - Specialty & Generic
Ranks #15 of 29 by Smart Score